Chronic Kidney Disease Market Research Report by Treatment Type (Dialysis, Medication, and Kidney Transplantation). MRFR Suggests that renal disease market is anticipated to listing a CAGR of 6.32% to reach USD 133,451.06 million till 2023. Increased Prevalence of Kidney Disorder Influencing the Global Renal Disease Market
Major Leading Market Players
Abbott (US), Amgen Inc. (US), AstraZeneca (US), Bristol-Myers Squibb Company (US), F. Hoffmann-La Roche Ltd (Switzerland), Fresenius Medical Care AG & Co. KGaA (UK), GlaxoSmithKline PLC (UK), Keryx Biopharmaceuticals, Inc (US), Kissei Pharmaceutical Co., Ltd (Japan), Novartis AG (Switzerland), Pfizer Inc. (US), Sanofi SA (France), and Teva Pharmaceutical Industries Ltd (Israel).
GET FREE SAMPLE COPY @ https://www.marketresearchfuture.com/sample_request/3167
Renal Disease Market Overview
The data analysts at Market Research Future (MRFR) expect the global renal disease market to attain a valuation of USD 93,375.70 million by 2023. They also predict that the market will achieve a CAGR of 6.32% during the forecast period (2017-2023).
Renal diseases are divided into chronic kidney disease (CKD) and end-stage renal disease (ESRD). These types of diseases could lead to kidney failure. As CKD worsens, the patient eventually suffers from ESRD. As estimated by the National Institute of Diabetes and Digestive and Kidney Diseases, over 6,61,000 Americans were suffering from kidney failure in 2015.
Segmental Overview
A comprehensive segmental analysis of the Global Renal Disease Market is available in MRFR’s report. The segment analysis covers disease types, treatment types, and end uses.
By disease type, the market has been segmented into end-stage renal diseases (ESRD) and chronic kidney disease. The chronic kidney disease segment holds a significant share of the market in terms of revenue. In 2017, the segment commanded more than USD 60,200 Mn and is expected to highly attractive during the forecast period. By treatment type, the market has been segmented into kidney transplantation, medication, and dialysis. Based on end user, the market has been segmented into research and academic institutes, hospitals & clinics, and dialysis centers.
List of Tables
TABLE 1 MARKET SYNOPSIS
TABLE 2 LIST OF ASSUMPTIONS
TABLE 3 PRIMARY INTERVIEWS
TABLE 4 PRICING RANGE OF KIDNEY TREATMENT (ANNUAL COST)
TABLE 5 GLOBAL RENAL DISEASE MARKET, BY DISEASE TYPE, 2015–2023 (USD MILLION)
TABLE 6 GLOBAL RENAL DISEASE MARKET, FOR CHRONIC KIDNEY DISEASE, BY REGION, 2015–2023 (USD MILLION)
Continued…
List of Figures
FIGURE 1 GLOBAL RENAL DISEASE MARKET: STRUCTURE
FIGURE 2 RESEARCH PROCESS
FIGURE 3 TOP-DOWN AND BOTTOM-UP APPROACHES
FIGURE 4 VALUE CHAIN
FIGURE 5 GLOBAL RENAL DISEASE MARKET SHARE, BY DISEASE TYPE, 2017 (%)
FIGURE 6 GLOBAL RENAL DISEASE MARKET, BY DISEASE TYPE, 2017 & 2023 (USD MILLION)
Continued…
The Americas cover the maximum share of the global renal disease market. The stupendous performance of the regional market is the result of the rising prevalence of renal diseases, particularly among elderly people. Moreover, the availability of sophisticated healthcare facilities within the region has brought in excellent revenues in recent years. Also, the regional companies are stressing on conducting more research and development (R&D) and developing new products. These factors will also be supplemented by the growth in funding, which will help the region maintain its top position throughout the evaluation period.
The market development in the Asia Pacific is estimated to be the fastest in the worldwide market. The expansion of the third-party pharmaceutical companies in India, China, and Singapore has a big hand in the market growth. As per the analysis, in 2017, Australia accounted for 11.8% of the total market in the Asia Pacific. Additionally, the massive revenue-generating opportunities present in the regional market is attracting numerous new entrants.
Collect the detailed Research Information @
https://www.marketresearchfuture.com/reports/renal-disease-market-3167
Industry News
US-based small molecules drug developer Peloton Therapeutics is reportedly applied for an initial public offering (IPO). This move is expected to help fund the company with its late-stage clinical trials.
Browse Other Healthcare Related Reports
Transplant Diagnostics Market – Global Forecast 2018 – 2023
Multiple Sclerosis Treatment Market – Global Forecast 2017 – 2023
About Market Research Future:
MRFR team has supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country-level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with the technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312
